Literature DB >> 1370193

Paneth cell-like change of the prostate gland. A histological, immunohistochemical, and electron microscopic study.

M G Weaver1, F W Abdul-Karim, J Srigley, D G Bostwick, J Y Ro, A G Ayala.   

Abstract

Paneth cell-like change (PCLC) of the prostatic glandular epithelium was focally observed in one case of normal glandular epithelium, two cases of glandular and stromal hyperplasia, one case of prostatic intraepithelial neoplasia, and four cases of prostatic adenocarcinoma. The distinctive cells were characterized by bright, eosinophilic cytoplasmic granules on routine hematoxylin and eosin-stained material. The cytoplasmic granules in the benign prostatic epithelium were periodate-Schiff's procedure (PAS)-positive and diastase resistant and immunohistochemically negative for lysozyme, neuron-specific enolase, chromogranin, and serotonin. The eosinophilic granules in the prostatic intraepithelial neoplasia and adenocarcinoma cases were immunohistochemically positive for chromogranin, serotonin, and neuron-specific enolase, and negative for lysozyme. By electron microscopy the eosinophilic granules represented exocrine-like or lysosomal-like vesicles in the benign epithelium and neuro-endocrine granules in the malignant epithelium. The lesion represents a prostatic epithelial PCLC rather than a Paneth cell metaplasia. PCLC is the common histological manifestation of two different phenomena: (a) a PAS-positive and diastase-resistant eosinophilic cytoplasmic granular change in benign prostatic epithelium, and (b) endocrine differentiation with neuroendocrine granules in dysplastic and malignant prostatic epithelia. The importance of recognizing PCLC lies in its differentiation from other possible prostatic cytoplasmic inclusions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370193     DOI: 10.1097/00000478-199201000-00009

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  Expression of CD15 in normal and metaplastic Paneth cells of the digestive tract.

Authors:  A Ariza; D López; E M Castellà; C Muñoz; M J Zújar; J L Mate
Journal:  J Clin Pathol       Date:  1996-06       Impact factor: 3.411

2.  Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification.

Authors:  Kyung Park; Zhengming Chen; Theresa Y MacDonald; Javed Siddiqui; Huihui Ye; Andreas Erbersdobler; Maria M Shevchuk; Brian D Robinson; Martin G Sanda; Arul M Chinnaiyan; Himisha Beltran; Mark A Rubin; Juan Miguel Mosquera
Journal:  Hum Pathol       Date:  2014-06-26       Impact factor: 3.466

3.  Neuroendocrine differentiation in the setting of prostatic carcinoma: contemporary assessment of a consecutive series.

Authors:  Anuradha Gopalan; Hikmat Al-Ahmadie; Ying-Bei Chen; Judy Sarungbam; S Joseph Sirintrapun; Satish K Tickoo; Victor E Reuter; Samson W Fine
Journal:  Histopathology       Date:  2022-07-11       Impact factor: 7.778

4.  Anaplastic carcinoma of the pancreas with rhabdoid features and hyaline globule-like structures.

Authors:  Naoto Kuroda; Shin-Ichi Iwamura; Nokiaki Fujishima; Masahiko Ohara; Takashi Hirouchi; Keiko Mizuno; Yoshihiro Hayashi; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

5.  Paneth cell-like change in benign prostate can account for P504S (AMACR) reactivity.

Authors:  Kenneth A Iczkowski
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

6.  Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.

Authors:  Jonathan I Epstein; Mahul B Amin; Himisha Beltran; Tamara L Lotan; Juan-Miguel Mosquera; Victor E Reuter; Brian D Robinson; Patricia Troncoso; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

7.  B.E.A.R. GeneInfo: a tool for identifying gene-related biomedical publications through user modifiable queries.

Authors:  Guohui Zhou; Xinyu Wen; Hang Liu; Michael J Schlicht; Martin J Hessner; Peter J Tonellato; Milton W Datta
Journal:  BMC Bioinformatics       Date:  2004-04-29       Impact factor: 3.169

Review 8.  Lineage plasticity-mediated therapy resistance in prostate cancer.

Authors:  Alexandra M Blee; Haojie Huang
Journal:  Asian J Androl       Date:  2019 May-Jun       Impact factor: 3.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.